ContextVision AB (publ) (OSL:CONTX)

Market Cap	272.42M -40.3%
Revenue (ttm)	121.39M -15.2%
Net Income	860.72K -96.8%
EPS	0.01 -96.8%
Shares Out	74.64M
PE Ratio	316.50
Forward PE	34.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,464
Average Volume	60,852
Open	3.620
Previous Close	3.620
Day's Range	3.530 - 3.660
52-Week Range	2.700 - 6.350
Beta	0.18
RSI	62.67
Earnings Date	Apr 8, 2026

About ContextVision AB

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardio...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1989
• Employees: 43
• Stock Exchange: Oslo Børs
• Ticker Symbol: CONTX

Financial Performance

In 2025, ContextVision AB's revenue was 110.99 million, a decrease of -15.17% compared to the previous year's 130.84 million. Earnings were 787,000, a decrease of -96.81%.

Financial numbers in SEK